Riverpoint Wealth Management Holdings’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Riverpoint Wealth Management Holdings's PFE Position: Q4 2023 in Review
Riverpoint Wealth Management Holdings sold out of Pfizer (PFE) in Q4 2023, closing a stake of 10,397 shares — an estimated $345K sold.
Riverpoint Wealth Management Holdings first reported a position in PFE in Q2 2018 and held it in 18 quarters. The position peaked at $644K in Q4 2021. 2,936 funds tracked by Wall St. Rank hold PFE as of Q4 2023.
- Riverpoint Wealth Management Holdings reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
- Riverpoint Wealth Management Holdings sold 10,397 Pfizer shares in Q4 2023, an estimated $345K.
- Riverpoint Wealth Management Holdings first reported a position in Pfizer in Q2 2018 and held it in 18 quarters.
- Riverpoint Wealth Management Holdings's Pfizer position peaked at $644K in Q4 2021.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.
Based on Riverpoint Wealth Management Holdings's 13F filing for Q4 2023, filed 6 Feb 2024.